Welcome to our dedicated page for Enzon Pharma SEC filings (Ticker: ENZN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
enzon pharmaceuticals, inc., together with its subsidiaries, engages in licensing drug products. its marketed drug products include pegintron and sylatron. the company was founded in 1981 and is headquartered in cranford, new jersey.